0000914190-21-000202.txt : 20210804
0000914190-21-000202.hdr.sgml : 20210804
20210804160342
ACCESSION NUMBER: 0000914190-21-000202
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210802
FILED AS OF DATE: 20210804
DATE AS OF CHANGE: 20210804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FINKELSTEIN J J
CENTRAL INDEX KEY: 0001125610
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15070
FILM NUMBER: 211143930
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000707511
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521253406
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15245 SHADY GROVE ROAD
STREET 2: SUITE 470
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-208-9191
MAIL ADDRESS:
STREET 1: 15245 SHADY GROVE ROAD
STREET 2: SUITE 470
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC
DATE OF NAME CHANGE: 19950719
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-08-02
0000707511
REGENERX BIOPHARMACEUTICALS INC
RGRX
0001125610
FINKELSTEIN J J
C/O REGENERX BIOPHARMACEUTICALS, INC.
15245 SHADY GROVE ROAD, SUITE 470
ROCKVILLE
MD
20850
1
1
0
0
President and CEO
Common Stock
1712991
D
Stock Option (right to buy)
0.36
2022-06-30
Common Stock
500000
500000
D
Stock Option (right to buy)
0.64
2023-03-16
Common Stock
200000
200000
D
Stock Option (right to buy)
0.28
2027-09-01
Common Stock
150000
150000
D
Stock Option (right to buy)
0.21
2028-07-17
Common Stock
250000
250000
D
Stock Option (right to buy)
0.21
2029-05-15
Common Stock
650000
650000
D
Stock Option (right to buy)
0.30
2030-06-10
Common Stock
500000
500000
D
Convertible Promissory Note (right to buy)
0.12
2019-02-27
2024-02-27
Common Stock
104167
12500.00
D
Convertible Promissory Note (right to buy)
0.12
2019-05-13
2024-05-13
Common Stock
104167
12500.00
D
Convertible Promissory Note (right to buy)
0.36
2020-10-15
2025-10-15
Common Stock
27840
10000
D
Common Stock Warrant (right to buy)
0.18
2019-08-27
2024-02-27
Common Stock
78125
78125
D
Common Stock Warrant (right to buy)
0.18
2019-11-13
2024-05-13
Common Stock
78125
78125
D
Common Stock Warrant (right to buy)
0.45
2021-04-15
2025-10-15
Common Stock
20880
20880
D
Series A Common Stock Warrant (right to buy)
0.24
2021-06-30
2023-06-30
Common Stock
56250
56250
D
Series B Common Stock Warrant (right to buy)
0.28
2021-06-30
2026-06-30
Common Stock
56250
56250
D
Stock Option (right to buy)
0.28
2021-08-02
4
A
0
600000
0
A
2031-08-02
Common Stock
600000
600000
D
100% vested.
162,500 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22.
125,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.
150,000 shares vest on each of 8/2/21, 8/2/22, 8/2/23 and 8/2/24.
/s/ Andrew Nick as Attorney-in-Fact for J.J. Finkelstein pursuant to Power of Attorney previously filed.
2021-08-04